Company intelligence / Profile preview

ILOODA

South Korea

Ownership: Private
Development stage: Other

Overview

ILOODA’s devices (Secret RF, Velux Laser, Fraxis DUO) are commercialized and used globally for minimally-invasive skin and cosmetic procedures, offering reduced pain, customizable treatments, and clinical results in wrinkle/scar reduction, hair removal, and advanced skin resurfacing

Therapeutic areas: CardiovascularDermatology
Modalities: Device (energy-based—radiofrequency, laser, CO₂ laser, microneedling)
Industry: Therapeutic Medical Devices

Partnerships

Academic collaborations with universitiespartnerships with external research agencies and research institutions

Beyond the preview

Go deeper on ILOODA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ILOODA.

Explore the full profile